T1	intervention 78 90	Nodal Photon
T2	control 98 112	Proton Therapy
T3	condition 20 36	Cardiac Toxicity
T4	condition 41 51	Recurrence
T5	No-of-participants 557 566	Forty-one
T6	outcome-Measure 809 828	Cardiotoxicity risk
T7	outcome 1251 1276	risk of cardiac morbidity
T8	outcome 1613 1660	risk of breast cancer recurrence after 10Â years
T9	outcome 1751 1830	association between age of the patient and benefit from proton therapy was weak
T10	outcome 1990 2014	risk of cardiac toxicity
T11	control-value 2160 2164	0.9%
T12	intervention-value 2111 2115	2.9%
T13	intervention-value 1665 1670	0.10%
T14	control-value 1707 1712	0.02%
T15	intervention-value 1361 1365	1.0%
T16	intervention-value 1389 1393	0.5%
T17	control-value 1503 1508	0.13%
T18	intervention-value 1533 1538	0.06%
